MDxHealth
2 known investors
mdxhealth develops molecular diagnostic tests for urologic diseases, with a focus on prostate cancer. Its products—Confirm mdx, GPS mdx, and Exo mdx—help physicians assess cancer risk, address false-negative biopsies, and guide treatment decisions for patients.
Founders & leadership
WV
Wim Van CriekingeChief Scientific Officer
Investors · 2
Funding
SEC filings, press & company announcements$20M disclosed across 1 round · 2026
- $20Mdirect share offeringAug 2026 · 2 sourcesSource ↗
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does MDxHealth do?
- mdxhealth develops molecular diagnostic tests for urologic diseases, with a focus on prostate cancer. Its products—Confirm mdx, GPS mdx, and Exo mdx—help physicians assess cancer risk, address false-negative biopsies, and guide treatment decisions for patients.
- Who are MDxHealth's investors?
- MDxHealth's investors include Andera Partners, OrbiMed.
- How much funding has MDxHealth raised?
- MDxHealth has disclosed $20M raised across 1 round.